CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,467 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 6,448 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 6,250 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,464 shares (to pay taxes)
- 4 Open-market buy Chief Regulatory Officer bought 5,600 shares at $1.74 ($9,743)
- 4 Open-market buy Interim CEO & General Counsel bought 25,000 shares at $1.69 ($42,250)
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,509 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 31,734 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 33,302 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 95,413 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 19,984 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 33,470 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 4 of 18 · 352 filings